NOT-AI-01-018: COMPREHENSIVE INTERNATIONAL PROGRAM OF RESEARCH ON AIDS (CIPRA)

Department of Health
and Human Services (HHS)
NIH... Turning Discovery Into Health^®
COMPREHENSIVE INTERNATIONAL PROGRAM OF RESEARCH ON AIDS (CIPRA)

Release Date:  March 15, 2001

NOTICE:  NOT-AI-01-018

National Institute of Allergy and Infectious Diseases
 (http://www.niaid.nih.gov)

The Division of AIDS (DAIDS), National Institute of Allergy and Infectious 
Diseases (NIAID), National Institutes of Health (NIH), announces its new 
Comprehensive International Program of Research on AIDS (CIPRA).

CIPRA will support comprehensive research and development efforts in 
eligible nations to develop practical, affordable and acceptable methods 
to both prevent and treat HIV/AIDS in adults and children. The goals of 
CIPRA are to:

1. Provide long-term support for planning and implementing a comprehensive 
HIV/AIDS research agenda including, epidemiological, clinical and 
laboratory research on HIV/AIDS.  Such research should form the basis for 
the development and application of practical and affordable methods to 
prevent and treat HIV/AIDS in the host country(ies).

2. Enhance the capability and capacity of the applicant organization to 
conduct the research agenda that is relevant to the affected 
population(s).  Provide support for continual training of project staff at 
all levels, so that the organization can develop and maintain skilled 
staff.  Provide support for infrastructure (facilities, renovations, and 
equipment) and the organizational capability necessary to develop and 
sustain an ongoing research effort.

ELIGIBILITY. Applications must come from research or clinical care 
organizations located in resource-constrained countries (i.e. countries 
with per capita gross national product less than US $5,000). Potential 
applicants can determine eligibility by country using the following table 
that summarizes economic information and HIV data by country: 
http://www.worldbank.org/aids-econ/confront/appendix/apdxtbl2a.htm

Collaboration with investigators from the U.S. and other international 
organizations is encouraged, but is not required. No more than 20% of an 
award may be spent outside the host country(ies) to support collaboration.

Potential applicants will find detailed information on the CIPRA program, 
CIPRA applications, and CIPRA awards on the CIPRA website at 
http://www.niaid.nih.gov/daids/cipra/.

A straight-forward process for indicating interest in submitting a CIPRA 
application is described in the above website. Potential applicants should 
contact NIAID at CIPRA@niaid.nih.gov to initiate discussions.

INQUIRIES

CIPRA Web site: http://www.niaid.nih.gov/daids/cipra/

E-Mail to: CIPRA@niaid.nih.gov

If e mail is not available: 

Direct inquires regarding scientific, technical and programmatic issues 
to:

Dr. Rodney Hoff
Division of AIDS
National Institute of Allergy and Infectious Diseases
Room 4157, MSC-7628
6700-B Rockledge Drive
Bethesda, MD  20892-7628
Telephone:  (301) 496 6179
FAX:        (301) 493 0591
Email:      CIPRA@niaid.nih.gov

Direct inquires regarding application format and review to:

Dr. Peter Jackson 
Division of Extramural Activities  
National Institute of Allergy and Infectious Diseases
Room 2154, MSC-7616
6700-B Rockledge Drive
Bethesda, MD  20892-7616
Telephone:  (301) 496-8426
FAX:        (301) 402 2638
Email:      CIPRA@niaid.nih.gov

Direct inquiries regarding fiscal matters to:

Jane Unsworth
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases
Room (insert), MSC-7614
6700-B Rockledge Drive
Bethesda, MD  20892-7614
Telephone:  (301) 402-6824
E-mail:     CIPRA@niaid.nih.gov
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices